MAPT and Alzheimer disease: Moreover, the current list of AD biomarkers in the updated framework lacks markers capable of reflecting the pathological functions of misfolded proteins, such as the seeding activity of pathogenic tau or Aβ, as seen in the αSyn-SAA for PD and PrPSc-SAA for PrD.